Clinical Trial Update: Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the safety and potential clinical benefit of anti-influenza immunoglobulin intravenous in hospitalized adults with Influenza A (H3N2/H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza H1n1
• Influenza H3n2

Drugs mentioned

• anti-influenza immunoglobulin intravenous

Snippet

Sponsor: Emergent BioSolutions | Conditions: Influenza A H3N2, Influenza A H1N1 | Phase 2 | Status: COMPLETED | Results posted: 2020-10-05